Cited 5 times in
A randomised, placebo-controlled, multicentre, Phase 2 clinical trial to evaluate the efficacy and safety of GV1001 in patients with benign prostatic hyperplasia
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.